GleamWall
中文EN

DNLI Denali Therapeutics Inc.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1714899 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY37.0%
TTM EPS YoY41.1%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-33.9%
ROA-27.2%
ROIC (approx.)-50.8%
Asset turnover—

Leverage & solvency

Liabilities / assets26.2%
Debt / equity0.00x
Current ratio6.21x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.41x
Accruals ratio11.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$0$0
R&D expense$418.78M$396.44M
SG&A expense$136.56M$105.44M
Operating income-$555.34M-$487.34M
Income tax$102,000$68,000
Net income-$512.54M-$422.77M
EBITDA-$544.16M-$479.55M
EPS (basic)-2.97-2.57
EPS (diluted)-2.97-2.57
Weighted avg. shares (diluted)172.65M164.47M
Balance sheet
Cash & equivalents$205.33M$176.53M
Short-term investments$662.55M$657.37M
Receivables$0—
Inventory$0—
Current assets$900.66M$864.44M
PP&E, net$52.40M$55.24M
Intangibles$0—
Total assets$1.14B$1.37B
Current liabilities$98.35M$102.21M
Total liabilities$131.09M$144.50M
Shareholders' equity$1.01B$1.23B
Shares outstanding156.18M144.22M
Cash flow statement
Operating cash flow-$412.60M-$347.69M
Capital expenditure$9.50M$15.91M
Free cash flow-$422.10M-$363.61M
Investing cash flow$255.28M-$88.76M
Financing cash flow$189.22M$484.30M
Depreciation & amortization$11.18M$7.79M
Stock-based compensation$99.63M$102.88M

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.